Cargando…

Immunological imprinting of the antibody response in COVID-19 patients

In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also susceptible to six other coronaviruses, for which consecutive exposures to antigenically related and divergent seasonal coronaviruses are frequent. Despite the prevalence of COVID-19 pandemic and ongoing res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aydillo, Teresa, Rombauts, Alexander, Stadlbauer, Daniel, Aslam, Sadaf, Abelenda-Alonso, Gabriela, Escalera, Alba, Amanat, Fatima, Jiang, Kaijun, Krammer, Florian, Carratala, Jordi, García-Sastre, Adolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213790/ https://www.ncbi.nlm.nih.gov/pubmed/34145263 http://dx.doi.org/10.1038/s41467-021-23977-1

Ejemplares similares

Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients
por: Aydillo, Teresa, et al.
Publicado: (2020)

Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples
por: Escalera, Alba, et al.
Publicado: (2022)

Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

Host- and Pathogen-Related Factors for Acute Cardiac Events in Pneumococcal Pneumonia
por: Rombauts, Alexander, et al.
Publicado: (2020)

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model
por: Stadlbauer, Daniel, et al.
Publicado: (2018)

Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
por: Aydillo, Teresa, et al.
Publicado: (2022)

Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol
por: Rombauts, Alexander, et al.
Publicado: (2020)

Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses
por: Kainth, Mundeep K., et al.
Publicado: (2022)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

Dynamics of Gene Expression Profiling and Identification of High-Risk Patients for Severe COVID-19
por: Rombauts, Alexander, et al.
Publicado: (2023)

Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo
por: Nogales, Aitor, et al.
Publicado: (2019)

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin
por: Strohmeier, Shirin, et al.
Publicado: (2019)

Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study
por: Pallarès, Natàlia, et al.
Publicado: (2022)

Whole-Blood Gene Expression Profiles Associated with Mortality in Community-Acquired Pneumonia
por: Viasus, Diego, et al.
Publicado: (2023)

SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study
por: Cortés Martínez, Jordi, et al.
Publicado: (2022)

Systems Immunology: Revealing Influenza Immunological Imprint
por: Tomic, Adriana, et al.
Publicado: (2021)

SARS-CoV-2 Vaccines: Status Report
por: Amanat, Fatima, et al.
Publicado: (2020)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Stadlbauer, Daniel, et al.
Publicado: (2017)

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2019)

Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs
por: Aslam, Sadaf, et al.
Publicado: (2023)

Immunological imprinting: Understanding COVID-19
por: Koutsakos, Marios, et al.
Publicado: (2023)

A serological assay to detect SARS-CoV-2 seroconversion in humans
por: Amanat, Fatima, et al.
Publicado: (2020)

Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case–control matched multicentre study (BACTCOVID)
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2021)

Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies
por: Żak, Magdalena M., et al.
Publicado: (2021)

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
por: Stadlbauer, Daniel, et al.
Publicado: (2020)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

Group 1 and group 2 hemagglutinin stalk antibody response according to age
por: Sánchez-de Prada, Laura, et al.
Publicado: (2023)

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses
por: Amanat, Fatima, et al.
Publicado: (2018)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2019)

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
por: Wajnberg, Ania, et al.
Publicado: (2020)

Development of a Macrophage-Based ADCC Assay
por: Uccellini, Melissa B., et al.
Publicado: (2021)

Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study
por: Aranda, Judit, et al.
Publicado: (2022)

Immunodominance hierarchy after seasonal influenza vaccination
por: Sánchez-de Prada, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1iijtucov0qn3bo2fdr3j114nm